NVP-LXS196

1874276-76-2

2-Pyrazinecarboxamide, 3-amino-N-[3-(4-amino-4-methyl-1-piperidinyl)-2-pyridinyl]-6-[3-(trifluoromethyl)-2-pyridinyl]-

3-Amino-N-[3-(4-amino-4-methyl-1-piperidinyl)-2-pyridinyl]-6-[3-(trifluormethyl)-2-pyridinyl]-2-pyrazincarboxamid

3-Amino-N-[3-(4-amino-4-methyl-1-piperidinyl)-2-pyridinyl]-6-[3-(trifluoromethyl)-2-pyridinyl]-2-pyrazinecarboxamide

3-Amino-N-[3-(4-amino-4-méthyl-1-pipéridinyl)-2-pyridinyl]-6-[3-(trifluorométhyl)-2-pyridinyl]-2-pyrazinecarboxamide

3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl]-6-[3-(trifluoromethyl)pyridin-2-yl]pyrazine-2-carboxamide

NVP-LXS196

1874276-76-2 (free base)

3-amino-N-(3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl)-6-(3-(trifluoromethyl)pyridin-2-yl)pyrazine-2-carboxamide

Darovasertib

Darovasertib (LXS-196)

Glycogen synthase kinase-3 beta

JMJD7_HUMAN

KPCA_HUMAN

KPCT_HUMAN

LXS-196 free base

MFCD31544328

Protein kinase C alpha type

Protein kinase C theta type

US9452998, 9